These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 21047732)
1. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines. Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732 [TBL] [Abstract][Full Text] [Related]
2. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Bunt J; Hasselt NE; Zwijnenburg DA; Hamdi M; Koster J; Versteeg R; Kool M Int J Cancer; 2012 Jul; 131(2):E21-32. PubMed ID: 21964830 [TBL] [Abstract][Full Text] [Related]
3. Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress. Kokkinakis DM; Liu X; Chada S; Ahmed MM; Shareef MM; Singha UK; Yang S; Luo J Cancer Res; 2004 Oct; 64(20):7513-25. PubMed ID: 15492278 [TBL] [Abstract][Full Text] [Related]
4. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma. Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066 [TBL] [Abstract][Full Text] [Related]
5. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648 [TBL] [Abstract][Full Text] [Related]
6. Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma. Bunt J; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M PLoS One; 2011; 6(10):e26058. PubMed ID: 22016811 [TBL] [Abstract][Full Text] [Related]
7. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels. Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372 [TBL] [Abstract][Full Text] [Related]
8. The Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001 [TBL] [Abstract][Full Text] [Related]
9. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Di C; Liao S; Adamson DC; Parrett TJ; Broderick DK; Shi Q; Lengauer C; Cummins JM; Velculescu VE; Fults DW; McLendon RE; Bigner DD; Yan H Cancer Res; 2005 Feb; 65(3):919-24. PubMed ID: 15705891 [TBL] [Abstract][Full Text] [Related]
10. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways. Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460 [TBL] [Abstract][Full Text] [Related]
11. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. Adamson DC; Shi Q; Wortham M; Northcott PA; Di C; Duncan CG; Li J; McLendon RE; Bigner DD; Taylor MD; Yan H Cancer Res; 2010 Jan; 70(1):181-91. PubMed ID: 20028867 [TBL] [Abstract][Full Text] [Related]
12. A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing. Saulnier O; Zagozewski J; Liang L; Hendrikse LD; Layug P; Gordon V; Aldinger KA; Haldipur P; Borlase S; Coudière-Morrison L; Cai T; Martell E; Gonzales NM; Palidwor G; Porter CJ; Richard S; Sharif T; Millen KJ; Doble BW; Taylor MD; Werbowetski-Ogilvie TE Nat Cell Biol; 2024 Aug; 26(8):1233-1246. PubMed ID: 39025928 [TBL] [Abstract][Full Text] [Related]
13. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Boon K; Eberhart CG; Riggins GJ Cancer Res; 2005 Feb; 65(3):703-7. PubMed ID: 15705863 [TBL] [Abstract][Full Text] [Related]
14. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma. Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma. Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567 [TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells. von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356 [TBL] [Abstract][Full Text] [Related]
17. Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts. Philipova T; Baryawno N; Hartmann W; Pietsch T; Druid H; Johnsen JI; Ekström TJ Int J Oncol; 2011 Mar; 38(3):843-9. PubMed ID: 21184030 [TBL] [Abstract][Full Text] [Related]
18. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617 [TBL] [Abstract][Full Text] [Related]
20. The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma. Kumar A; Fillmore HL; Kadian R; Broaddus WC; Tye GW; Van Meter TE Mol Cancer Res; 2009 Nov; 7(11):1813-21. PubMed ID: 19887560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]